<VariationArchive VariationID="807613" VariationName="NM_002087.4(GRN):c.709-4_713del" VariationType="Deletion" Accession="VCV000807613" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2020-02-03" MostRecentSubmission="2020-02-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="798715" VariationID="807613">
      <GeneList>
        <Gene Symbol="GRN" FullName="granulin precursor" GeneID="2896" HGNC_ID="HGNC:4601" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44345302" stop="44353106" display_start="44345302" display_stop="44353106" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42422490" stop="42430469" display_start="42422490" display_stop="42430469" Strand="+" />
          </Location>
          <OMIM>138945</OMIM>
        </Gene>
        <Gene Symbol="LOC125177489" FullName="Sharpr-MPRA regulatory region 15390" GeneID="125177489" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44350781" stop="44351075" display_start="44350781" display_stop="44351075" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_002087.4(GRN):c.709-4_713del</Name>
      <CanonicalSPDI>NC_000017.11:44351028:CCACTCAGGCCAC:CCAC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44351029" stop="44351037" display_start="44351029" display_stop="44351037" variantLength="9" positionVCF="44351028" referenceAlleleVCF="CCCACTCAGG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42428397" stop="42428405" display_start="42428397" display_stop="42428405" variantLength="9" referenceAllele="CCCACTCAGG" alternateAllele="C" positionVCF="42428396" referenceAlleleVCF="CCCACTCAGG" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42428401_42428409del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42428401_42428409del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44351033_44351041del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44351033_44351041del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007886.1" sequenceAccession="NG_007886" sequenceVersion="1" change="g.10911_10919del">
            <Expression>NG_007886.1:g.10911_10919del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002087.4" sequenceAccession="NM_002087" sequenceVersion="4" change="c.709-4_713del" MANESelect="true">
            <Expression>NM_002087.4:c.709-4_713del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_661" sequenceAccession="LRG_661">
            <Expression>LRG_661:g.10911_10919del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1598364296" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002087.4(GRN):c.709-4_713del AND GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" Accession="RCV000995783" Version="5">
        <ClassifiedConditionList TraitSetID="5202">
          <ClassifiedCondition DB="MedGen" ID="C1843792">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-06-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-06-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-02-03" MostRecentSubmission="2020-02-03">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="5202" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5167" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0016" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FTLD-TDP, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Frontotemporal dementia, ubiquitin-positive</ElementValue>
                <XRef ID="Frontotemporal+Dementia%2C+Ubiquitin-Positive/2945" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dementia, hereditary dysphasic disinhibition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ElementValue>
                <XRef ID="MONDO:0011842" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRN-Related Frontotemporal Dementia</ElementValue>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FTDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FTLDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HDDD</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000530102" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of GRN frontotemporal dementia (GRN-FTD) includes the behavioral variant (bvFTD), primary progressive aphasia (PPA; further subcategorized as progressive nonfluent aphasia [PNFA] and semantic dementia [SD]), and movement disorders with extrapyramidal features such as parkinsonism and corticobasal syndrome (CBS). A broad range of clinical features both within and between families is observed. The age of onset ranges from 35 to 87 years. Behavioral disturbances are the most common early feature, followed by progressive aphasia. Impairment in executive function manifests as loss of judgment and insight. In early stages, PPA often manifests as deficits in naming, word finding, or word comprehension. In late stages, affected individuals often become mute and lose their ability to communicate. Early findings of parkinsonism include rigidity, bradykinesia or akinesia (slowing or absence of movements), limb dystonia, apraxia (loss of ability to carry out learned purposeful movements), and disequilibrium. Late motor findings may include myoclonus, dysarthria, and dysphagia. Most affected individuals eventually lose the ability to walk. Disease duration is three to 12 years.</Attribute>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301545</ID>
                <ID Source="BookShelf">NBK1371</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="100070" DB="Orphanet" />
              <XRef ID="282" DB="Orphanet" />
              <XRef ID="C1843792" DB="MedGen" />
              <XRef ID="MONDO:0011842" DB="MONDO" />
              <XRef Type="MIM" ID="607485" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2268338" SubmissionDate="2020-01-21" DateLastUpdated="2020-02-03" DateCreated="2020-02-03">
        <ClinVarSubmissionID localKey="286-20200121" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001150131" DateUpdated="2020-02-03" DateCreated="2020-02-03" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München" OrgID="500240" OrganizationCategory="clinic" OrgAbbreviation="IHG-MRI-TUM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Classification criteria August 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/inodbbrd/classification_criteria.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <FamilyData PedigreeID="625-20200121" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">625-20200121</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="C" referenceAllele="CCCACTCAGG" start="42428396" stop="42428405" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607485" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6902622</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2268338" TraitType="Disease" MappingType="XRef" MappingValue="607485" MappingRef="OMIM">
        <MedGen CUI="C1843792" Name="GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

